Peptinov
PrivateLast Round
Grant
Jun 24, 2024
Total Funding Raised
$19.15M
Company Overview
Peptinov is a biotechnology company that develops innovative active immunotherapy treatments for chronic inflammatory diseases and cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Peptinov Comparables
Compare Peptinov with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neovacs | 80% | |
| 4Moving Biotech | 78% | |
| Biosplice Therapeutics | 68% |
Peptinov Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 24, 2024 | ||||
| Grant | Apr 23, 2024 | ||||
| Accelerator | Oct 1, 2023 | ||||
| Grant | Oct 1, 2023 | ||||
| Venture - Series Unknown | May 23, 2023 | ||||
VC Round | Mar 1, 2023 |
Key People
Founding team and executive leadership
Peptinov Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Happy Capital | Seed, VC Round |
| Les Business Angels des Grandes Écoles | Angel, VC Round |
| European Innovation Council Fund | Grant, Accelerator |
| Groupe IRCEM | VC Round |
| WiSeed | Seed |
| Bpifrance | Grant |
| IRCEM Prévoyance | Venture - Series Unknown, Seed, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Web traffic grew 40% MoM (from 349 to 487 monthly visitors)
- Mar 1, 2023
$5M raised led by Groupe IRCEM and IRCEM Prévoyance.
Peptinov Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Peptinov's valuation, stock price, and market status.
Is Peptinov a public or private company?
Peptinov is a private company.
What is the current stock price of Peptinov?
Peptinov is a private company with no public stock price. No recent secondary market data is available.
How much is Peptinov worth (valuation)?
Valuation information for Peptinov is not publicly available.
Can I buy Peptinov stock?
Peptinov shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Peptinov's last funding round?
Peptinov's most recent funding round was Grant on April 23, 2024.
Who are the main investors in Peptinov?
Key investors in Peptinov include Bpifrance, IRCEM Prévoyance.
Will Peptinov IPO soon?
No public IPO plans have been announced for Peptinov.
How can I track Peptinov secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Peptinov's secondary market activity and sign up for updates.